xpeer logo
© Xpeer 2026 All rights reserved
Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Genomic Testing in Oncology

5

Free
1h 1min
Audio: English
Subtitles: German +4

Synopsis

Cancer care is rapidly evolving, driven by increasing biological complexity and the need for more precise, timely, and personalised approaches to diagnosis and treatment. In this course, leading experts explore the future of oncology applications, focusing on how emerging technologies such as liquid biopsy, comprehensive genomic profiling (CGP), and whole exome sequencing (WES) and whole genome and transcriptome sequencing (WGTS) are transforming clinical practice. Through a series of video modules, participants will gain insight into how these approaches improve diagnostic accuracy, guide therapy selection, enable detection of resistance and disease monitoring, and support earlier and less invasive testing strategies. The course also highlights the added value of combining different omics to unlock a deeper understanding of tumour biology, alongside practical considerations for clinical implementation, including workflow integration, turnaround time, and data interpretation.

This activity is supported by an independent support grant from Illumina

Objectives

After completing this activity, participants should be better prepared to:

  • Describe the role of genomic technologies (CGP, liquid biopsy, WES, WGTS) in cancer care
  • Explain how these approaches improve diagnosis, patient stratification, and therapy selection
  • Evaluate the clinical utility of advanced genomic testing across different stages of the patient pathway
  • Recognise the impact of emerging technologies (e.g., liquid biopsy, multi-omics) on understanding tumour biology
  • Apply key considerations for integrating genomic testing into routine clinical practice

Duration

1h 1min

Target audience

Medical genetics

Authors

Prof. Isabelle Ray-Coquard

Prof. Isabelle Ray-Coquard is a medical oncologist at Centre Léon Bérard, Lyon, France, specializing in gynecological cancers and sarcomas. She is a leader in translational oncology research and has held prominent leadership roles within international gynecologic oncology research networks.

Testimonials

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

Read more reviews onTrustpilot

FAQs

What you will learn

Tissue CGP

  • Benefits of next-generation sequencing (NGS) biomarker testing for cancer patients
  • CGP utility in lung cancer
  • Does finding a rare mutation accomplish anything?
  • Testing for NTRK fusions
  • How can CGP, including HRD testing, help guide patient treatment?
  • HRD testing in ovarian cancer

Liquid CGP

  • Introduction to ctDNA-based liquid biopsy
  • Liquid biopsy NGS in cancer care
  • Clinical utility of ctDNA testing in lung cancer
  • How can ctDNA-guided MRD testing benefit patients with colorectal cancer?

WES and WGTS

  • What are the benefits of WES in comparison to targeted small panels?
  • WGTS testing in sarcomas
  • How does incorporating WGS into routine diagnosis benefit patients with AML?

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account